Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

08.01.2024

1 Cancer Res
3 Curr Opin Obstet Gynecol
2 Gynecol Oncol
1 Obstet Gynecol
1 Oncogene
1 PLoS One



    Cancer Res

  1. BEDDOWS I, Fan H, Heinze K, Johnson BK, et al
    Cell state of origin impacts development of distinct endometriosis-related ovarian carcinoma histotypes.
    Cancer Res. 2023 Oct 24. doi: 10.1158/0008-5472.CAN-23-1362.
    >> Share


    Curr Opin Obstet Gynecol

  2. GARCIA-ILLESCAS D, Mazzeo R, Garcia-Duran C, Oaknin A, et al
    The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era.
    Curr Opin Obstet Gynecol. 2024 Jan 3. doi: 10.1097/GCO.0000000000000934.
    >> Share

  3. ALI M, Tewari KS
    A review of racial disparities in ovarian cancer and clinical trials.
    Curr Opin Obstet Gynecol. 2024;36:23-27.
    >> Share

  4. SALUTARI V, Giudice E, Lorusso D
    Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives.
    Curr Opin Obstet Gynecol. 2024;36:9-17.
    >> Share


    Gynecol Oncol

  5. ALSOMAIRI A, Himayda S, Altelmesani A, Lee YJ, et al
    Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125.
    Gynecol Oncol. 2024;181:155-161.
    >> Share

  6. WU MF, Cheng XY, Wang DY, Lai YT, et al
    Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial.
    Gynecol Oncol. 2023;181:125-132.
    >> Share


    Obstet Gynecol

  7. GREENWOOD A, Woodruff ER, Nguyen C, Piper C, et al
    Early Ovarian Cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review.
    Obstet Gynecol. 2024 Jan 4. doi: 10.1097/AOG.0000000000005496.
    >> Share


    Oncogene

  8. WU CJ, Pan KF, Chen JQ, Tao Y-, et al
    Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment.
    Oncogene. 2024 Jan 4. doi: 10.1038/s41388-023-02918.
    >> Share


    PLoS One

  9. YOO MY, Woo KJ, Kang SY, Moon BS, et al
    Efficacy of preoperative lymphoscintigraphy in predicting surgical outcomes of lymphaticovenous anastomosis in lower extremity lymphedema: Clinical correlations in gynecological cancer-related lymphedema.
    PLoS One. 2024;19:e0296466.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016